June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...

In a significant turn of events, Ann Wojcicki's non-profit, TTAM Research Institute, has secured a deal to purchase the ...

Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...

Oklahoma Attorney General joins 27 other states in a lawsuit against 23andMe to prevent the company from selling private DNA ...

Pennsylvania Attorney General Dave Sunday continues to advise customers of the DNA-testing company 23andMe to delete their data from its database as it attempts to sell sensitive information ...

Texas Attorney General Ken Paxton is looking to protect Texans' genetic data with action filed this week in ongoing 23andMe ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

A coalition of US states has sued 23andMe to block the sale of user DNA data without explicit consent. Filed in bankruptcy court, the suit challenges the transfer of genetic profiles linked to over 15 ...

The sale of 23andMe's genetic database to Regeneron shows gaps in Australia's cross-border data protection laws for sensitive health information.